Faeth Therapeutics, Inc. (FTH)
NASDAQ · Manufacturing · Pharmaceutical preparations
$28.00−$1.05 (−3.61%) on the dayAs of the close; data may be delayed.
FTH price, last 12 months
Key stats
- Previous close
- $29.05
- Open
- $28.93
- Day range
- $27.60 – $28.93
- 52-week range
- $13.43 – $42.14
- Volume
- 328.2K
- Avg volume (20 days)
- 452.1K
- Market cap
- $723.5M
Performance
1W−18.8%
1M−15.1%
3M+22.4%
6M—
YTD—
1Y—
Technicals and fundamentals
About Faeth Therapeutics, Inc.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $723.5M